Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

Dignass, Axel, Lindsay, James O., Sturm, Andreas, Windsor, Alastair, Colombel, Jean-Frederic, Allez, Mathieu, D'Haens, Gert, D'Hoore, André, Mantzaris, Gerassimos, Novacek, Gottfried, Öresland, Tom, Reinisch, Walter, Sans, Miquel, Stange, Eduard, Vermeire, Severine, Travis, Simon, Van Assche, Gert·2012·Journal of Crohn's and Colitis
DOI 10.1016/j.crohns.2012.09.002

Cited by (1,000)

Items 701–800 of 1,000

  1. Therapeutic drug monitoring of tumour necrosis factor inhibitors in the management of chronic inflammatory diseases
    José Germán Sánchez‐Hernandez, Noemí Rebollo, Fernándo Muñoz, Ana Martín‐Suárez, M V Calvo · 2018 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  2. Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease
    Anne Grosen, Jacob Nersting, Mona Bungum, Lisbet Ambrosius Christensen, Kjeld Schmiegelow, Marcello Spanò, Mette Julsgaard, Eugenia Cordelli, Giorgio Leter, Peter B. Larsen et al. · 2018 · Journal of Crohn s and Colitis
  3. Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis
    Belinda D. Jackson, Peter P. De Cruz · 2018 · Expert Review of Gastroenterology & Hepatology
  4. Evaluating mucosal healing using colon capsule endoscopy predicts outcome in patients with ulcerative colitis in clinical remission
    Ryosuke Takano, Satoshi Osawa, Takahiro Uotani, Shinya Tani, Natsuki Ishida, Satoshi Tamura, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Takahisa Furuta et al. · 2018 · World Journal of Clinical Cases
  5. The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
    Wai Ching Lam, Chen Zhao, Wen Juan Ma, Liang Yao · 2019 · Gastroenterology Research and Practice
  6. Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis
    Kata Szemes, Alexandra Soós, Péter Jenő Hegyi, Nelli Farkas, Adrienn Erös, Bálint Mihály Erőss, Emese Mezősi, Zsolt Szakács, Katalin Márta, Patrícia Sarlós · 2020 · Frontiers in Medicine
  7. Predictors of health-related quality of life in patients with moderate to severely active ulcerative colitis receiving biological therapy
    Bjørn Rasmussen, Peter Haastrup, Sonja Wehberg, Jens Kjeldsen, Frans Boch Waldorff · 2020 · Scandinavian Journal of Gastroenterology
  8. Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
    Kacper Nijakowski, Rafał Rutkowski, Piotr Eder, Katarzyna Korybalska, Janusz Witowski, Anna Surdacka · 2021 · Life
  9. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders
    Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia · 2021 · World Journal of Hepatology
  10. Management of ulcerative colitis: a clinical update
    Fábio Vieira Teixeira, Rogerio Saad Hosne, Carlos Walter Sobrado · 2015 · Journal of Coloproctology
  11. Adherence to online monitoring of patient-reported outcomes by patients with chronic inflammatory diseases: a feasibility study
    Yvan Jamilloux, Matthieu Sarabi, Sébastien Kerever, Nolga Boussely, Anne Le Sidaner, Virginie Valgueblasse, Paul Carrier, Véronique Loustaud-Ratti, Denis Sautereau, A.L. Fauchais et al. · 2015 · Lupus
  12. Disease Course and Colectomy Rate of Ulcerative Colitis
    Natalia Manetti, Siro Bagnoli, Francesca Rogai, Andrea G. Bonanomi, Giancarlo Vannozzi, Martina Giannotta, Vito Annese · 2016 · Inflammatory Bowel Diseases
  13. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis
    Brian P. Bosworth, William J. Sandborn, David T. Rubin, Joseph R. Harper · 2016 · Inflammatory Bowel Diseases
  14. The Pattern of Underlying Cause of Death in Patients with Inflammatory Bowel Disease in England: A Record Linkage Study
    Thomas P. C. Chu, Gordon William Moran, Tim R Card · 2016 · Journal of Crohn s and Colitis
  15. Potential role of regulatory B cells in immunological diseases
    Valizadeh, Amir, Sanaei, Roozbeh, Rezaei, Nima, Azizi, Gholamreza, Fekrvand, Saba, Aghamohammadi, Asghar, Yazdani, Reza · 2019 · Immunology Letters
  16. New and emerging treatments for ulcerative colitis: a focus on vedolizumab
    Keith Bodger, Gledhill · 2013 · Biologics
  17. Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
    Lingya Yao, Bule Shao, Feng Tian, Mei Ye, Yuqin Li, Xiaolei Wang, Lin Wang, Shaoqi Yang, Xiaoping Lv, Yan Jia et al. · 2022 · World Journal of Gastroenterology
  18. Clinical Diagnosis and Phar-maceutical Management of Inflammatory Bowel Disease
    Amosy Ephreim M’Koma · 2023 · Medical Research Archives
  19. Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease
    Jeff Y. Yang, Jennifer Leigh Lund, Michele Jönsson Funk, Michael G. Hudgens, James D. Lewis, Michael D. Kappelman · 2023 · The American Journal of Gastroenterology
  20. Celecoxib alleviates the DSS-induced ulcerative colitis in mice by enhancing intestinal barrier function, inhibiting ferroptosis and suppressing apoptosis
    Yaxian Li, Mengdi Ma, Xiaodong Wang, Jing Li, Ziqing Fang, Jianhui Li, Bo Yang, Yida Lu, Xin Xu, Yongxiang Li · 2023 · Immunopharmacology and Immunotoxicology
  21. Ulcerative colitis: current pharmacotherapy and future directions
    Cristina Bezzio, Federica Furfaro, Roberto de Franchis, Giovanni Maconi, Anil Kumar Asthana, Sandro Ardizzone · 2014 · Expert Opinion on Pharmacotherapy
  22. Initial experience with golimumab in clinical practice for ulcerative colitis
    Luisa Castro Laria, Federico Argüelles‐Arias, Valle García-Sánchez, J M Benítez, Ramón Fernández-Pérez, Ana María Trapero-Fernández, Francisco Gallardo Sánchez, Héctor Pallarés Manrique, María Gómez–García, M J Cabello Tapia et al. · 2016 · Revista Española de Enfermedades Digestivas
  23. Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts
    Alessandro Armuzzi, Carla Felice, Ennio Lubrano, Fabrizio Cantini, Fabiana Castiglione, Paolo Gionchetti, Ambrogio Orlando, Carlo Salvarani, Raffaele Scarpa, Antonio Marchesoni et al. · 2017 · Digestive and Liver Disease
  24. Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease
    Christian P. Selinger, Marco Vincenzo Lenti, Tanya Clark, Helen Rafferty, David J. Gracie, Alexander Charles Ford, Anthony O’Connor, Tariq Ahmad, Peter John Hamlin · 2017 · Inflammatory Bowel Diseases
  25. Inflammatory bowel disease patients prioritize mucosal healing, symptom control, and pain when choosing therapies: results of a prospective cross-sectional willingness-to-pay study
    James C. Gregor, Martin Williamson, Dorota Dajnowiec, Bernie D. Sattin, Erik Sabot, Baljinder S. Salh · 2018 · Patient Preference and Adherence
  26. Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers
    Míriam Mañosa, María Chaparro, Alba Juan Juan, Clàudia Aràjol, Ignacio Alfaro, Miguel Mínguez, Benito Velayos, J M Benítez, Francisco Mesonero, Beatriz Sicilia et al. · 2019 · The American Journal of Gastroenterology
  27. Comparative assessment of budesonide‐MMX and mesalamine in active, mild‐to‐moderate ulcerative colitis: A systematic review and network meta‐analysis
    Stefanos Bonovas, Georgios K. Nikolopoulos, Daniele Piovani, Marien González‐Lorenzo, Katerina G. Pantavou, Theodore Lytras, Laurent Peyrin‐Biroulet, Silvio Danese · 2019 · British Journal of Clinical Pharmacology
  28. Astragaloside II alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo.
    Cuixia Qiao, Jin′e Wan, Lize Zhang, Bo Luo, Penglin Liu, Aiting Di, Hairui Gao, Xiaomei Sun, Gang Zhao · 2019 · PubMed Central
  29. Managing ambulatory ulcerative colitis patients with infliximab: A long-term follow-up study in primary gastroenterology centers
    Antonio Tursi, Walter Elisei, Marcello Picchio, Antônio Penna, Piera Giuseppina Lecca, Giacomo Forti, GianMarco Giorgetti, Roberto Faggiani, Costantino Zampaletta, Giorgio Pelecca et al. · 2014 · European Journal of Internal Medicine
  30. Budesonide foam for mild to moderate distal ulcerative colitis: A systematic review and meta‐analysis
    Jian Zeng, Lin Lv, Zhechuan Mei · 2016 · Journal of Gastroenterology and Hepatology
  31. Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
    Marco Daperno, Alessandro Armuzzi, Silvio Danese, Walter Fries, Giuseppina Liguori, Ambrogio Orlando, Claudio Papi, Mariabeatrice Principi, Fernando Rizzello, Angelo Viscido et al. · 2019 · Gastroenterology Research and Practice
  32. Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment
    Emilio G. Quetglas, Alessandro Armuzzi, Simone Wigge, Gionata Fiorino, Lutz Barnscheid, Marcel Froelich, Silvio Danese · 2015 · European Journal of Clinical Pharmacology
  33. Concerns related to COVID‐19 pandemic among patients with inflammatory bowel disease and its influence on patient management
    Giorgia Bodini, Maria Giulia Demarzo, Edoardo Casagrande, Costanza De Maria, Stefano Kayali, Sebastiano Ziola, Edoardo Giovanni Giannini · 2020 · European Journal of Clinical Investigation
  34. Aloe emodin promotes mucosal healing by modifying the differentiation fate of enteroendocrine cells via regulating cellular free fatty acid sensitivity
    Weilian Bao, Jiaren Lyu, Guize Feng, Linfeng Guo, Dian Zhao, Keyuan You, Yang Liu, Haidong Li, Peng Du, Daofeng Chen et al. · 2024 · Acta Pharmaceutica Sinica B
  35. Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
    Taku Kobayashi, Eri Udagawa, Akihito Uda, Toshifumi Hibi∥, Tadakazu Hisamatsu · 2019 · Journal of Gastroenterology and Hepatology
  36. Effect of TrkB-PLC/IP3 pathway on intestinal inflammatory factors and enterocyte apoptosis in mice with colitis
    Guangmeng Xu, Yajuan Sun, Huaiqiang He, Qiuli Xue, Yajie Liu, Lihua Dong · 2020 · Acta Biochimica et Biophysica Sinica
  37. The role of oral vancomycin in inducing remission for biologic-experienced ulcerative colitis with concomitant primary sclerosing cholangitis and liver transplantation
    Asad Ur Rahman, Faisal Inayat, Saeed Ali, Effa Zahid, Roger Charles · 2020 · Clinical Journal of Gastroenterology
  38. Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience
    Sami Hoque, Amy Puenpatom, Simona Boccaletti, Chloe Green, Christopher Matthew Black, Jenna S. Roberts, Ivana Rajkovic, Gary Milligan · 2020 · BMJ Open Gastroenterology
  39. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Noninvasive Predictors of the Therapeutic Outcomes of Systemic Corticosteroid Therapy in Ulcerative Colitis
    Katsuya Endo, Tomonori Satoh, Yuki Yoshino, Shiho Kondo, Yoko Kawakami, Tomofumi Katayama, Yoshiteru Sasaki, Atsuko Takasu, Takayuki Kogure, Morihisa Hirota et al. · 2021 · Inflammatory Intestinal Diseases
  40. Clinical relevance of endoscopic peri-appendiceal red patch in ulcerative colitis patients
    Maud A. Reijntjes, Lianne Heuthorst, Krisztina Barbara Gecse, Aart Mookhoek, Willem Adrianus Bemelman, Christianne Johanna Buskens · 2022 · Therapeutic Advances in Gastroenterology
  41. Analysis of clinical characteristics of mesalazine-induced cardiotoxicity
    Junyu Chen, Tengfei Duan, Weijin Fang, Shikun Liu, Chunjiang Wang · 2022 · Frontiers in Pharmacology
  42. From Hair to Colon: Hair Follicle‐Derived MSCs Alleviate Pyroptosis in DSS‐Induced Ulcerative Colitis by Releasing Exosomes in a Paracrine Manner
    Yuan Chang, Yichi Zhang, Yanan Jiang, Lei Zhao, Chengqian Lv, Qianqian Huang, Jing-Ming Guan, Shizhu Jin · 2022 · Oxidative Medicine and Cellular Longevity
  43. Probiotics in Irritable Bowel Syndrome: A Review Article
    Shatakshi Sharma, Sunil Kumar, Sheeral Sajjad, Samriddhi Sharma · 2023 · Cureus
  44. Identification of hub genes and immune infiltration in ulcerative colitis using bioinformatics
    Weitao Hu, Taiyong Fang, Mingxuan Zhou, Xiaoqing Chen · 2023 · Scientific Reports
  45. A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses
    Shaocong Mo, Bryan Jin, Yujen Tseng, Lingxi Lin, Lishuang Lin, Xin Shen, Huan Song, Mingjia Kong, Zhongguang Luo, Yiwei Chu et al. · 2023 · Journal of Translational Medicine
  46. Personalized Treatment for Crohn’s Disease: Current Approaches and Future Directions
    Joseph William Clinton, Raymond Keith Cross · 2023 · Clinical and Experimental Gastroenterology
  47. Safety of Proctocolectomy for Ulcerative Colitis Under Elective and Non-Elective Circumstances: Preoperative Corticosteroid Treatment Worsens Outcome
    Rogini Balachandran, Anders Tøttrup · 2015 · Digestive Surgery
  48. Cost of Ulcerative Colitis in Quebec, Canada
    Andrei Dan, Marylise Boutros, Hacene Nedjar, Uri Kopylov, Waqqas Afif, Maria Abou-Khalil, Elham Rahme · 2017 · Inflammatory Bowel Diseases
  49. Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice
    Sara van Gennep, Nanne K.H. de Boer, Geert D’Haens, Mark Löwenberg · 2017 · Inflammatory Bowel Diseases
  50. Use, effectiveness and tolerability of budesonide‐MMX in ulcerative colitis: A real‐life experience
    Giovanni Maconi, Nicolò Mezzina, Stefano Landi, Simone Grillo, Cristina Bezzio, Matteo Bosani, Luca Pastorelli, Alessandra Dell’Era, Richa Chibbar, Stefania Carmagnola et al. · 2019 · United European Gastroenterology Journal
  51. UK National Survey of Gastroenterologists’ attitudes and barriers toward therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease
    Gaurav Bhaskar Nigam, Shadab Nayeemuddin, Evangelos Kontopantelis, Bu Hayee, Jimmy K. Limdi · 2020 · Frontline Gastroenterology
  52. Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland
    Paweł Wojciech Petryszyn, Pawel Ekk-Cierniakowski, Grzegorz Zurakowski · 2020 · Therapeutic Advances in Gastroenterology
  53. Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
    Brigida Barberio, Edoardo Vincenzo Savarino, Tim R Card, Cristina Canova, Francesco Baldisser, Alessandro Gubbiotti, Davide Massimi, Matteo Ghisa, Fabiana Zingone · 2021 · Intestinal Research
  54. Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
    Sara Campos, Francisco A. Portela, Luís Tomé · 2017 · International Journal of Colorectal Disease
  55. Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study
    Arie Levine, Baruch Yerushalmi, Michal Kori, Efrat Broide, Yael Mozer‐Glassberg, Ron R. Shaoul, Kaija‐Leena Kolho, Eyal Shteyer, Hussein Shamaly, Oren Ledder et al. · 2017 · Journal of Crohn s and Colitis
  56. Enfermedad inflamatoria intestinal: características de fenotipo y tratamiento en un hospital universitario de Bogotá, Colombia.
    Gustavo Adolfo Reyes Medina, Fabio Leonel Gil Parada, Germán David Carvajal, Carlos Bernardo Sánchez Luque, Diego Mauricio Aponte, Carlos Arturo González, Johana Gamba, Javier Alberto Preciado Aponte, Juan Carlos Marulanda, Luis Carlos Sabbagh Sanvicente · 2018 · Revista Colombiana de Gastroenterología
  57. Mesalamine-Induced Myopericarditis: A Case Report and Literature Review
    Mohamed Taha, Abubaker Abdalla, Jaafar F. Al-Khafaji, Samira Malik · 2019 · Cardiology Research
  58. DOP044 Patient education in a 14 month randomized trial fails to improve adherence in ulcerative colitis: Influence of demographic and clinical parameters on non-adherence
    Susanna Nikolaus, Stefan Schreiber, Britta Siegmund, Bernd Bokemeyer, Elke Bästlein, Oliver P. Bachmann, Wolfgang Kruis · 2014 · Journal of Crohn s and Colitis
  59. A Questionnaire-Based Survey on the Diagnosis and Management of Inflammatory Bowel Disease in East Asian Countries in 2012
    Nobuyuki Hida, Shirô Nakamura, Ki‐Baik Hahm, Jose Decena Sollano, Qi Zhu, Abdul Aziz Rani, Ari Fahrial Syam, Udom Kachintorn, Fumiaki Ueno, Takashi Joh et al. · 2014 · Digestion
  60. Relation of geriatric nutritional risk index with clinical risks in elderly‐onset ulcerative colitis
    Masaaki Higashiyama, Shunsuke Komoto, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi∥, Soichiro Miura, Ryota Hokari · 2020 · Journal of Gastroenterology and Hepatology
  61. Comparing the clinical application values of the Degree of Ulcerative Colitis Burden of Luminal Inflammation (DUBLIN) score and Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in patients with ulcerative colitis
    Xiaofei Zhang, Peng Li, Xueli Ding, Hao Chen, Shaojun Wang, Sheng-Bo Jin, Jing Guo, Zibin Tian · 2021 · Gastroenterology report
  62. Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial
    Wolfgang Kruis, Britta Siegmund, Konrad Leśniakowski, Vladimir I. Simanenkov, Л. В. Хіміон, Marcin Soboń, Glebs Delmans, Svetlana V Maksyashina, Oleg A. Sablin, Juris Pokrotnieks et al. · 2022 · Journal of Crohn s and Colitis
  63. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review
    Lana M. Agraib, Mohammed I. Yamani, Yaser Mohammed Rayyan, Awni T. Abu Sneineh, Tarek Tamimi, Reema Tayyem · 2021 · Drug Metabolism and Personalized Therapy
  64. Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries
    Hyun Kyeong Yoo, Han Geul Byun, Flavio Caprioli, Mathurin Fuméry, Laurent Peyrin‐Biroulet, Subramanian Sreedhar, James Potter, Minyoung Jang · 2022 · BMC Health Services Research
  65. Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing
    Noriyuki Kurimoto, Yu Nishida, Shuhei Hosomi, Shigehiro Itani, Yumie Kobayashi, Rieko Nakata, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani et al. · 2023 · PLoS ONE
  66. Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis
    Harpreet Singh, Liam Wilson, Tom Tencer, Jinender Kumar · 2023 · ClinicoEconomics and Outcomes Research
  67. Identification of Critical Modules and Biomarkers of Ulcerative Colitis by Using WGCNA
    Yifan Yuan, Na Li, Mingyue Fu, Mei Ye · 2023 · Journal of Inflammation Research
  68. Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature
    Thaís Gagno Grillo, da Silva Mazeto Pupo Silveira Caroline Ferreira, Ana Elisa Valencise Quaglio, Renata de Medeiros Dutra, Júlio Pinheiro Baima, Silméia Garcia Zanati Bazan, Lígia Yukie Sassaki · 2023 · World Journal of Cardiology
  69. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease
    Sisi Zhou, Zeyu Huang, Wenjing Hou, Yiting Lin, Jing Yu · 2024 · Inflammation Research
  70. Sarcopenia is common in ulcerative colitis and correlates with disease activity
    Pardhu Bharath Neelam, Rimesh Pal, Pankaj C. Gupta, Anupam Kumar Singh, Jimil Shah, Harshal Surendra Mandavdhare, Harjeet Singh, Aravind Sekar, Sanjay Kumar Bhadada, Usha Dutta et al. · 2024 · Intestinal Research
  71. An assessment system for clinical and biological interpretability in ulcerative colitis
    Shiqian Zhang, Ge Zhang, Wenxiu Wang, Song‐Bin Guo, Pengpeng Zhang, Fuqi Wang, Quanbo Zhou, Zhaokai Zhou, Yujia Wang, Haifeng Sun et al. · 2024 · Aging
  72. Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis
    Jin Hui Yu · 2015 · World Journal of Gastroenterology
  73. Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study
    Ekaterina Safroneeva, Stephan R. Vavricka, Nicolas Fournier, Alex Straumann, Gerhard Rogler, Alain M. Schoepfer · 2015 · Inflammatory Bowel Diseases
  74. Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression
    C Lutz, M Mozaffari, Vinko Toševski, Michaela Caj, Pietro E. Cippà, Bradford L. McRae, Candace L. Graff, Gerhard Rogler, Michael Fried, Martin Hausmann · 2015 · Clinical & Experimental Immunology
  75. Current management of intestinal bowel disease: the role of surgery
    Gaspare Solina, Stefano Mandalà, C. Barbera, Vincenzo Mandalà · 2016 · Updates in Surgery
  76. Effect of roxithromycin on mucosal damage, oxidative stress and pro-inflammatory markers in experimental model of colitis
    Hilal Ahmad, Sneh Verma, Vijay L. Kumar · 2017 · Inflammation Research
  77. How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system
    Anita Bálint, Klaudia Farkas, Zoltán Szepes, Ferenc Tamás Nagy, Mónika Szűcs, László Tiszlavicz, Renáta Bor, Ágnes Milassin, Mariann Rutka, Anna Fábián et al. · 2018 · BMC Gastroenterology
  78. Validación de un nuevo índice integral de enfermedad para evaluar el grado de actividad en pacientes mexicanos con colitis ulcerosa: un estudio de cohorte prospectivo
    Jesus Kazuo Yamamoto-Furusho, Katya Estefanía Bozada-Gutiérrez, Alain Sánchez-Rodríguez, F. Bojalil-Romano, Rafael Barreto‐Zúñiga, Braulio Martínez‐Benítez · 2019 · Revista de Gastroenterología de México
  79. Validation of a novel integral disease index for evaluating the grade of activity in Mexican patients with ulcerative colitis: A prospective cohort study
    Jesus Kazuo Yamamoto-Furusho, Katya Estefanía Bozada-Gutiérrez, Alain Sánchez-Rodríguez, F. Bojalil-Romano, Rafael Barreto‐Zúñiga, Braulio Martínez‐Benítez · 2019 · Revista de Gastroenterología de México (English Edition)
  80. A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild‐to‐moderate ulcerative colitis
    Silvio Danese, Ailsa L Hart, Axel U Dignass, Gionata Fiorino, Edouard J. Louis, Stefanos Bonovas, Geert D’Haens, Iris Dotan, Gerhard Rogler, Kristine Paridaens et al. · 2019 · United European Gastroenterology Journal
  81. Constipation in ulcerative colitis: pathophysiology and practical management
    Charles Miller, Anton V Emmanuel, Natalia Zárate-López, Stuart Andrew Taylor, Stuart L Bloom · 2020 · Frontline Gastroenterology
  82. Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis
    Fernando Magro, María Manuela Estevinho, Cláudia Camila Dias, Luís Correia, Paula M. Lago, Paula Ministro, Francisco Portela, Roger M. Feakins, Silvio Danese, Laurent Peyrin‐Biroulet · 2020 · Journal of Crohn s and Colitis
  83. Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis
    Camille Vong, Steven W. Martin, Chenhui Deng, Rujia Xie, Kaori Ito, Chinyu G. Su, William J. Sandborn, Arnab Mukherjee · 2021 · Clinical Pharmacology in Drug Development
  84. Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting
    Markus Ries, Brice Moulari, Maryam A. Shetab Boushehri, Mohamed Ehab Ali, Daniel Molnar, Arnaud Béduneau, Yann Pellequer, Alf Lamprecht · 2022 · Pharmaceutics
  85. Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
    HanZheng Zhao, Wenhui Zhang, Die Cheng, Liuping You, Yuenan Huang, Yanjie Lu · 2022 · Frontiers in Medicine
  86. Ileal pouch-anal anastomosis: Points of controversy
    A. Trigui, Faten Frikha, Haitham Rejab, H. Ben Ameur, Hana Triki, Mohamed Ben Amar, Rafik Mzali · 2014 · Journal of Visceral Surgery
  87. Health-related quality of life assessment among patients with inflammatory bowel diseases after surgery – review
    Grażyna Bączyk, Dorota Formanowicz, Łukasz Gmerek, Piotr Krokowicz · 2017 · Gastroenterology Review
  88. Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
    Angelo Viscido, Claudio Papi, Giovanni Latella, Giuseppe Frieri · 2019 · Biologics
  89. Vaccination status of patients using anti-TNF therapy and the physicians’ behavior shaping the phenomenon: Mixed-methods approach
    Hussain Abdulrahman Al‐Omar, Hadeel Magdy Sherif, Ahmed Yacoob Mayet · 2019 · PLoS ONE
  90. Evaluation of interleukin 23 (IL-23) as a non-invasive test of disease severity in patients with ulcerative colitis
    Tarek Mohammed Youssef, Shereen Abo Baker Saleh, Angie Rund, Iman Fawzy Montasser, Manal Mohsen, Ola Hazem · 2018 · Arab Journal of Gastroenterology
  91. Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
    Davide Giuseppe Ribaldone, Alessandro Adriani, Gian Paolo Caviglia, Amedeo De Nicolò, Danilo Agnesod, Marco Simiele, Danila Riganò, Rinaldo Pellicano, Roberto Canaparo, Giovanni Di Perri et al. · 2019 · Medicina
  92. The Role of an Inflammatory Bowel Disease Nurse in the Follow-Up of Patients From a Latin American Inflammatory Bowel Disease Program
    Daniela Simian, Lilian Flores, Rodrigo Quera, Patricio Ibáñez L, Carolina Figueroa, Jaime Lubascher, Gonzalo Pizarro, Udo Kronberg · 2020 · Gastroenterology Nursing
  93. Quality of life in postostomy surgery patients: A cross‐sectional survey
    Kristina Aluzaite, James W Nuttall, Maree O'Connor, Ruth Harvie, Michael Schultz · 2020 · JGH Open
  94. Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis
    Morris A. Gordon, Vassiliki Sinopoulou, Anthony Kwaku Akobeng, Mirela Pana, Rehab Gasiea, Gordon William Moran · 2022 · Cochrane Database of Systematic Reviews
  95. Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis
    Xiaoyan Lu, James Jarrett, Susannah Sadler, Min Tan, James W. Dennis, Vipul Jairath · 2022 · International Journal of Clinical Pharmacy
  96. Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe
    Ran Jin, Chidozie U Nduka, Delphine Courmier, Hannah Knight, Rachael Meadows, James Piercy, Fraser J.R. Cummings, Waldemar Radziszewski · 2023 · Advances in Therapy
  97. MnO2 and roflumilast-loaded probiotic membrane vesicles mitigate experimental colitis by synergistically augmenting cAMP in macrophage
    Chengjun Song, Jiamin Wu, Jinhui Wu, Fangyu Wang · 2024 · Journal of Nanobiotechnology
  98. Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Munira Essat, Paul Tappenden, Shijie Ren, Alice Bessey, Rachel J. Archer, Ruth Wong, Alan Lobo, Sami Hoque · 2015 · PharmacoEconomics
  99. State-of-the-Art Surgical Approaches to the Treatment of Medically Refractory Ulcerative Colitis
    Liliana Bordeianou, Lillias Holmes Maguire · 2013 · Journal of Gastrointestinal Surgery
  100. Eventos adversos en la terapia farmacológica de la enfermedad inflamatoria intestinal
    Lital Meyer, Daniela Simian, Jaime Lubascher, Raúl Acuña, Carolina Figueroa, Silva Guillermo, J Brahm, Rodrigo Quera · 2015 · Revista médica de Chile